EWBC:NASDAQEast West Bancorp, Inc. Analysis
Data as of 2026-06-18 - not real-time
$126.81
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
East West Bancorp (EWBC) is trading at $126.81, comfortably above its 20‑day SMA ($125.83) and 50‑day SMA ($123.11) while still below the 200‑day SMA ($112.68) trend line, indicating a bullish bias. Technical indicators such as a bullish MACD crossover (line 2.13 vs signal 2.07) and a neutral RSI (53.7) support continued upside, with the price holding above the identified support of $119.49 and approaching the resistance near $136. Fundamentally, the stock trades at a PE of 12.7 versus an industry average of 16.9 and a P/B of 1.93, suggesting it is undervalued. The DCF fair value of $207.91 implies an upside of roughly 8.4%, and the dividend yield of 2.45% with a modest 26% payout ratio points to sustainable income. Market sentiment is extremely bullish, reflected by a Fear & Greed Index reading of 92 (Extreme Greed), and volume is on an increasing trend, adding confidence to the price action. Overall, EWBC combines solid earnings growth (14% revenue growth), strong profitability margins, and a robust cash position, making it an attractive candidate for investors seeking both value and growth exposure.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key SMAs and bullish MACD
- Undervalued valuation relative to peers and DCF upside
- Sustainable dividend yield supporting total return
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings growth and high ROE (~16%)
- Continued dividend sustainability with low payout ratio
- Gap between market price and DCF fair value indicating upside potential
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust cash position and low leverage enhancing balance‑sheet resilience
- Long‑term valuation upside of >8% plus attractive dividend income
- Strategic positioning in US‑Asia trade finance supporting future growth
Key Metrics & Analysis
Financial Health
Revenue Growth14.10%
Profit Margin50.00%
P/E Ratio12.7
ROE16.45%
ROA1.75%
P/B Ratio1.9
Op. Cash Flow$1.7B
Industry P/E16.9
Technical Analysis
TrendBullish
RSI53.7
Support$119.49
Resistance$136.00
MA 20$125.83
MA 50$123.11
MA 200$112.68
MACDBullish
VolumeIncreasing
Fear & Greed Index92.14
Valuation
Fair Value$207.91
Target Price$137.44
Upside/Downside8.38%
GradeUndervalued
TypeBlend
Dividend Yield2.45%
Risk Assessment
Beta0.99
Volatility21.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.